Published in J Immunol on August 01, 1996
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med (2005) 5.77
Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity (2009) 2.61
Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev (2008) 1.88
Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med (1999) 1.70
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol (2010) 1.67
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med (2009) 1.66
Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun (1997) 1.52
IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol (2009) 1.46
Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine (2010) 1.36
Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res (2010) 1.32
Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun (1998) 1.31
Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun (2008) 1.26
T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol (1998) 1.20
Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol (2013) 1.17
Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. J Exp Med (1997) 1.08
Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol (1999) 1.00
Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology (2003) 0.95
Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells. Br J Pharmacol (2000) 0.93
Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol (1998) 0.92
IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity. Immunology (2005) 0.91
Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci U S A (2004) 0.87
CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev (2014) 0.87
Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis. Vet Parasitol (2009) 0.86
c-jun controls the ability of IL-12 to induce IL-10 production from human memory CD4+ T cells. J Immunol (2009) 0.85
IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression. Mucosal Immunol (2010) 0.83
Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway. Br J Pharmacol (2001) 0.82
Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism. PLoS One (2016) 0.78
Lck regulates IL-10 expression in memory-like Th1 cells. Eur J Immunol (2010) 0.76
CD4+CD25high regulatory cells in human peripheral blood. J Immunol (2001) 11.25
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng (2001) 5.71
Bacteria and aetiology of cancer of large bowel. Lancet (1971) 5.16
T-strain mycoplasma in non-gonococcal urethritis. Lancet (1966) 5.16
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature (1998) 4.10
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol (1994) 4.07
Overexpression of the maize homeo box gene, KNOTTED-1, causes a switch from determinate to indeterminate cell fates. Genes Dev (1993) 3.77
Bacteria and the aetiology of cancer of the large bowel. Gut (1969) 3.57
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med (1997) 3.46
Effects of oral administration of type II collagen on rheumatoid arthritis. Science (1993) 3.32
Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees. Genet Epidemiol (1984) 3.11
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (1993) 2.97
Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol (1989) 2.95
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (1992) 2.89
Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science (1990) 2.86
GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol (1996) 2.60
Problems created for ice arenas by engine exhaust. Am Ind Hyg Assoc J (1971) 2.49
Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol (1998) 2.47
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1994) 2.45
The cell walls of streptococci. J Gen Microbiol (1965) 2.42
Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology (2008) 2.41
Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40
Tick-borne diseases in the United States. N Engl J Med (1993) 2.39
Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med (1994) 2.37
Structural and thermodynamic consequences of burying a charged residue within the hydrophobic core of T4 lysozyme. Biochemistry (1991) 2.31
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
Gut bacteria and aetiology of cancer of the breast. Lancet (1971) 2.29
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med (1995) 2.28
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest (1996) 2.27
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med (1985) 2.27
Phage typing of staphylococci. Bull World Health Organ (1961) 2.23
Identification and molecular cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni. Mol Microbiol (1997) 2.17
Treatment of Bacillary (Flexner) Dysentery with Sulphanilylguanidine. Br Med J (1941) 2.15
Studies of the effectiveness of an isolation ward. J Hyg (Lond) (1969) 2.10
Effects of high-probability requests on the acquisition and generalization of responses to requests in young children with behavior disorders. J Appl Behav Anal (1992) 2.03
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest (2000) 2.00
T-cell recognition of myelin basic protein. Immunol Today (1991) 1.98
Hereditary aspects of malignant melanoma. JAMA (1967) 1.98
Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A (1997) 1.95
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol (1992) 1.91
Antibiotic resistance of coagulase-negative staphylococci and micrococci. J Clin Pathol (1968) 1.91
Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation (1991) 1.91
Heredity and cancer in man. Prog Med Genet (1973) 1.91
Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A (1992) 1.88
The impact of gunshot wounds on an orthopaedic surgical service in an urban trauma center. J Orthop Trauma (1997) 1.87
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol (1991) 1.85
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol (1998) 1.82
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology (1993) 1.81
Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. Biochemistry (1991) 1.79
Bimodal activation of SMC ATPase by intra- and inter-molecular interactions. EMBO J (2001) 1.78
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J Mol Biol (2001) 1.68
Some characteristics of familial breast cancer. Cancer (1971) 1.67
De motu urbanorum. Br Med J (1975) 1.67
Genetic study of breast cancer: identification of a high risk group. Cancer (1974) 1.66
Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med (1993) 1.64
Cancer risk and diet in India. J Postgrad Med (2003) 1.62
Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem Biophys Res Commun (1998) 1.62
Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med (1988) 1.62
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A (2000) 1.61
Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis (1998) 1.59
Phage typing of coagulase-negative staphylococci and micrococci. J Hyg (Lond) (1973) 1.59
Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol (1994) 1.58
Nasal acquisition of Staphylococcus aureus in partly divided wards. J Hyg (Lond) (1971) 1.57
Cost of treating an infected total knee replacement. Clin Orthop Relat Res (1996) 1.56
Thermal comfort during surgical operations. J Hyg (Lond) (1968) 1.56
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol (1998) 1.53
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
MS: a CNS and systemic autoimmune disease. Immunol Today (1989) 1.47
Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology (1999) 1.46
Effects of phenylbutazone on bone activity and formation in horses. Am J Vet Res (2000) 1.45
Pre-weaning morbidity and mortality of llamas and alpacas. Aust Vet J (2009) 1.44
Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol (1989) 1.43
Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer (1969) 1.41
Articular fractures of the distal portion of the humerus in Vietnamese pot-bellied pigs: six cases (1988-1992) J Am Vet Med Assoc (1995) 1.41
Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet (1998) 1.41
Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J Immunol (2001) 1.39
The effect of prostatectomy on symptom severity and quality of life. Br J Urol (1996) 1.39
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Engl J Med (1987) 1.38
Characterization of the human granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem (1988) 1.35
A genetic study of human breast cancer. J Natl Cancer Inst (1972) 1.34
Antigen reactive memory T cells are defined by Ta1. J Immunol (1986) 1.33
Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer (1971) 1.33
Control of Meloidogyne chitwoodi in Potato with Fumigant and Nonfumigant Nematicides. J Nematol (2000) 1.32
Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging (2008) 1.31
T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med (1992) 1.30
Effects of high-probability requests on the social interactions of young children with severe disabilities. J Appl Behav Anal (1994) 1.29
Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med (1992) 1.29
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother (1996) 1.28
Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J Immunol (1987) 1.27
Breast cancer in families. Cancer (1977) 1.27
The nevoid basal cell carcinoma syndrome. Am J Hum Genet (1967) 1.26
Bridging scientist and practitioner perspectives in clinical psychology. Am Psychol (1995) 1.26